PubMed:19389916 / 606-781
Annnotations
Glycosmos6-MAT
{"project":"Glycosmos6-MAT","denotations":[{"id":"T1","span":{"begin":151,"end":156},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"T2","span":{"begin":151,"end":156},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T5","span":{"begin":0,"end":175},"obj":"Sentence"},{"id":"T5","span":{"begin":0,"end":175},"obj":"Sentence"},{"id":"T5","span":{"begin":0,"end":175},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro."}
GlycoBiology-FMA
{"project":"GlycoBiology-FMA","denotations":[{"id":"_T7","span":{"begin":45,"end":50},"obj":"FMAID:167330"},{"id":"_T8","span":{"begin":95,"end":101},"obj":"FMAID:162307"},{"id":"_T9","span":{"begin":134,"end":143},"obj":"FMAID:167145"},{"id":"_T10","span":{"begin":134,"end":143},"obj":"FMAID:62851"},{"id":"_T11","span":{"begin":151,"end":156},"obj":"FMAID:256053"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro."}
GO-BP
{"project":"GO-BP","denotations":[{"id":"T3","span":{"begin":151,"end":165},"obj":"http://purl.obolibrary.org/obo/GO_0007596"},{"id":"T4","span":{"begin":157,"end":165},"obj":"http://purl.obolibrary.org/obo/GO_0050817"}],"text":"Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro."}
UBERON-AE
{"project":"UBERON-AE","denotations":[{"id":"T5","span":{"begin":45,"end":50},"obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"T8","span":{"begin":151,"end":156},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T9","span":{"begin":151,"end":165},"obj":"http://purl.obolibrary.org/obo/UBERON_0010210"}],"text":"Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro."}
GlycoBiology-MAT
{"project":"GlycoBiology-MAT","denotations":[{"id":"T1","span":{"begin":151,"end":156},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"},{"id":"T2","span":{"begin":151,"end":156},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"}],"text":"Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro."}
performance-test
{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T4","span":{"begin":151,"end":156},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"PD-UBERON-AE-B_T9","span":{"begin":45,"end":50},"obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"PD-UBERON-AE-B_T12","span":{"begin":151,"end":165},"obj":"http://purl.obolibrary.org/obo/UBERON_0010210"}],"text":"Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro."}
Anatomy-MAT
{"project":"Anatomy-MAT","denotations":[{"id":"T1","span":{"begin":151,"end":156},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A2","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro."}
NCBITAXON
{"project":"NCBITAXON","denotations":[{"id":"T4","span":{"begin":39,"end":44},"obj":"OrganismTaxon"}],"attributes":[{"id":"A4","pred":"db_id","subj":"T4","obj":"9606"}],"text":"Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro."}
Anatomy-UBERON
{"project":"Anatomy-UBERON","denotations":[{"id":"T2","span":{"begin":95,"end":101},"obj":"Body_part"},{"id":"T3","span":{"begin":134,"end":143},"obj":"Body_part"},{"id":"T4","span":{"begin":151,"end":156},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL_0000233"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro."}
CL-cell
{"project":"CL-cell","denotations":[{"id":"T2","span":{"begin":134,"end":143},"obj":"Cell"}],"attributes":[{"id":"A2","pred":"cl_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL:0000233"}],"text":"Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro."}